François A. Leblond

966 total citations
22 papers, 632 citations indexed

About

François A. Leblond is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, François A. Leblond has authored 22 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in François A. Leblond's work include Pharmacogenetics and Drug Metabolism (5 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). François A. Leblond is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). François A. Leblond collaborates with scholars based in Canada, United States and Belgium. François A. Leblond's co-authors include Vincent Pichette, Judith Naud, Josée Michaud, János G. Filep, Carl Guévin, Denis Lebel, Pierre Dubé, Jean‐Pierre Hallé, Karine Desbiens and Alain Bonnardeaux and has published in prestigious journals such as Biomaterials, Scientific Reports and Biochemical Journal.

In The Last Decade

François A. Leblond

22 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François A. Leblond Canada 13 169 147 125 115 113 22 632
Takafumi Kuzuya Japan 16 183 1.1× 69 0.5× 133 1.1× 131 1.1× 155 1.4× 43 716
M B Affrime United States 14 151 0.9× 65 0.4× 116 0.9× 91 0.8× 95 0.8× 46 765
William J. Jusko United States 13 59 0.3× 118 0.8× 90 0.7× 86 0.7× 190 1.7× 17 607
H. Wietholtz Germany 16 217 1.3× 245 1.7× 326 2.6× 81 0.7× 130 1.2× 31 986
Taiichi Kaku Japan 19 110 0.7× 117 0.8× 390 3.1× 178 1.5× 117 1.0× 39 793
Jian‐Quan Luo China 17 84 0.5× 108 0.7× 200 1.6× 61 0.5× 213 1.9× 42 709
Ryota Tanaka Japan 16 81 0.5× 71 0.5× 127 1.0× 80 0.7× 295 2.6× 90 850
P. J. McKiernan United Kingdom 16 175 1.0× 48 0.3× 77 0.6× 124 1.1× 229 2.0× 40 792
Michael J. Knauer Canada 12 126 0.7× 92 0.6× 191 1.5× 101 0.9× 94 0.8× 25 603
Zhican Wang United States 19 66 0.4× 95 0.6× 135 1.1× 164 1.4× 235 2.1× 31 1.1k

Countries citing papers authored by François A. Leblond

Since Specialization
Citations

This map shows the geographic impact of François A. Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François A. Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François A. Leblond more than expected).

Fields of papers citing papers by François A. Leblond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François A. Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François A. Leblond. The network helps show where François A. Leblond may publish in the future.

Co-authorship network of co-authors of François A. Leblond

This figure shows the co-authorship network connecting the top 25 collaborators of François A. Leblond. A scholar is included among the top collaborators of François A. Leblond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François A. Leblond. François A. Leblond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
West, Raymond E., et al.. (2019). Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease. Scientific Reports. 9(1). 15901–15901. 15 indexed citations
2.
Thibodeau, Jean-François, Jean-Christophe Simard, Chet E. Holterman, et al.. (2019). PBI-4050 via GPR40 activation improves adenine-induced kidney injury in mice. Clinical Science. 133(14). 1587–1602. 11 indexed citations
3.
Sidéris, Lucas, et al.. (2018). Rationale for the administration of systemic 5-FU in combination with heated intraperitonal oxaliplatin. Surgical Oncology. 27(2). 275–279. 7 indexed citations
4.
Grouix, Brigitte, Martin Leduc, Jean-Christophe Simard, et al.. (2018). PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway. Journal of Pharmacology and Experimental Therapeutics. 367(1). 71–81. 22 indexed citations
5.
Naud, Judith, et al.. (2015). Pharmacocinétique des médicaments en insuffisance rénale : nouveautés. Néphrologie & Thérapeutique. 11(3). 144–151. 4 indexed citations
6.
Alshogran, Osama Y., Andrew J. Ocque, Jielu Zhao, et al.. (2013). Determination of warfarin alcohols by ultra-high performance liquid chromatography–tandem mass spectrometry: Application to in vitro enzyme kinetic studies. Journal of Chromatography B. 944. 63–68. 14 indexed citations
7.
Leblond, François A., et al.. (2009). Regulation of the proprotein convertase subtilisin/kexin type 9 in intestinal epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(4). G805–G815. 26 indexed citations
8.
Lajoie, Julie, Johanne Poudrier, Marguerite Massinga Loembé, et al.. (2009). Chemokine Expression Patterns in the Systemic and Genital Tract Compartments are Associated with HIV-1 Infection in Women from Benin. Journal of Clinical Immunology. 30(1). 90–98. 25 indexed citations
9.
Michaud, Josée, François A. Leblond, Judith Naud, et al.. (2006). Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine. Journal of Pharmacological and Toxicological Methods. 55(2). 209–213. 5 indexed citations
10.
Bendavid, Yves, François A. Leblond, & Pierre Dubé. (2005). A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat.. PubMed. 11(1). BR1–5. 10 indexed citations
11.
Michaud, Josée, Pierre Dubé, Judith Naud, et al.. (2005). Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. British Journal of Pharmacology. 144(8). 1067–1077. 85 indexed citations
12.
Dusseault, Julie, François A. Leblond, Robert Robitaille, et al.. (2004). Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials. 26(13). 1515–1522. 75 indexed citations
13.
Pichette, Vincent & François A. Leblond. (2003). Drug Metabolism in Chronic Renal Failure. Current Drug Metabolism. 4(2). 91–103. 85 indexed citations
14.
Guévin, Carl, Josée Michaud, Judith Naud, François A. Leblond, & Vincent Pichette. (2002). Down‐regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators. British Journal of Pharmacology. 137(7). 1039–1046. 90 indexed citations
15.
Leblond, François A., et al.. (1998). Peroxynitrite production by human neutrophils, monocytes and lymphocytes challenged with lipopolysaccharide. FEBS Letters. 431(1). 107–110. 54 indexed citations
16.
Hallé, Jean‐Pierre, et al.. (1993). PROTECTION OF ISLETS OF LANGERHANS FROM ANTIBODIES BY MICROENCAPSULATION WITH ALGINATE-POLY-L-LYSINE MEMBRANES1. Transplantation. 55(2). 350–354. 45 indexed citations
17.
Leblond, François A., et al.. (1991). In resting conditions, the pancreatic granule membrane protein GP-2 is secreted by cleavage of its glycosylphosphatidylinositol anchor. Biochemical Journal. 277(3). 879–881. 22 indexed citations
18.
Leblond, François A., et al.. (1989). A competition enzyme-linked immunosorbent assay (ELISA) for the measurement of pancreatic GP-2 glycoprotein. Journal of Immunological Methods. 124(1). 71–75. 4 indexed citations
19.
Grondin, Gilles, François A. Leblond, Jean Morisset, & Denis Lebel. (1989). Light and Electron Microscopy of the Exocrine Pancreas in the Chronically Reserpinized Rat. Pediatric Research. 25(5). 482–489. 7 indexed citations
20.
Leblond, François A., Jean Morisset, & Denis Lebel. (1989). Alterations of Pancreatic Growth and of GP-2 Content in the Reserpinized Rat Model of Cystic Fibrosis. Pediatric Research. 25(5). 478–481. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takafumi Kuzuya Breakdown of academic impact, for papers by M B Affrime Breakdown of academic impact, for papers by William J. Jusko Breakdown of academic impact, for papers by H. Wietholtz Breakdown of academic impact, for papers by Taiichi Kaku Breakdown of academic impact, for papers by Jian‐Quan Luo Breakdown of academic impact, for papers by Ryota Tanaka Breakdown of academic impact, for papers by P. J. McKiernan Breakdown of academic impact, for papers by Michael J. Knauer Breakdown of academic impact, for papers by Zhican Wang
Rankless by CCL
2026